Cardiac Surgeries Segment to Dominate Middle East & Africa Autotransfusion Devices Market during 2019–2028

According to a new market research study on “Middle East & Africa Autotransfusion Devices Market to 2028 – COVID-19 Impact and Regional Analysis and Forecast by Type, Application, and End User,” is expected to reach US$ 57.69 million by 2028 from US$ 46.03 million in 2021. The market is estimated to grow at a CAGR of 3.3% from 2021 to 2028. Rapid surge in chronic diseases is the major factor driving the growth of the Middle East & Africa autotransfusion devices market. However, product recalls may hinder the growth of Middle East & Africa autotransfusion devices market. The report provides trends prevailing in the Middle East & Africa autotransfusion devices market along with the drivers and restraints pertaining to the market growth.

The Middle East & Africa autotransfusion devices market is segmented into type, application, end user, and country. The Middle East & Africa autotransfusion devices market, by type, is segmented into products and accessories. In 2021, the accessories segment held the largest share Middle East & Africa autotransfusion devices market. The products is further sub-segmented into intraoperative autotransfusion systems, postoperative autotransfusion systems, and dual-mode autotransfusion systems. In 2021, the intraoperative autotransfusion systems segment held the largest share Middle East & Africa autotransfusion devices market. The Middle East & Africa autotransfusion devices market, by application, is segmented into cardiac surgeries, orthopedic surgeries, organ transplantation, trauma procedures, and others. The cardiac surgeries segment held the largest share of the market in 2021. Based on end user, the Middle East & Africa autotransfusion devices market is segmented hospitals, specialty clinics, and ambulatory surgical centers. The hospitals segment held the largest share of the market in 2021. Similarly, based on country, the Middle East & Africa autotransfusion devices market is segmented into Saudi Arabia, the UAE, South Africa, and the rest of Middle East & Africa. Saudi Arabia contributed a substantial share in 2021. 

BD, Braile Biomedica, Fresenius SE & Co. KGaA, Haemonetics Corporation, Medtronic, Redax S.p.A., SARSTEDT AG and Co. KG, Teleflex Incorporated, and Zimmer Biomet are among the leading companies in the Middle East & Africa autotransfusion devices market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market. For instance, in 2020, Medtronic received FDA approval for its advanced autoLog IQ Autotransfusion System. The newly approved system offers postoperative autotransfusion mechanism in cardiovascular, orthopedics, neurology, and other types of surgeries.

Middle East & Africa Autotransfusion Devices Market, By Country, 2020 and 2028 (%) 

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com